@maclaudiaa @juliauraji In the past decade, different FSH doses and different ovarian stimulation algorithms have been compared in multiple RCTs. These have been summarised in a @CochraneCGF review. #eshrejc https://t.co/EvpVuP4I5c

@MaybeBaby_32 Hola guapa, no tengo mucho tiempo para investigar demasiado pero esto me ha parecido interesante para q lo vieras. Si veo algo más te digo. https://t.co/oQhqdvJDsQ

@paulpharoah Counterpoint: these sorts of trials *are* done: https://t.co/FuUZ3lzSqL

@exactsake Does that follow? The idea is that applying the individualisation algorithm should improve outcomes in the population. That can be tested. Indeed, such trials are done: https://t.co/FuUZ3lzSqL

@MaartenvSmeden How about a systematic review full of them? I hear this one almost killed the statistician: https://t.co/FuUZ3lzSqL

Another document supporting the trend of reducing medication in IVF patient. @cphfertility #patientsafety https://t.co/K7urRLrm7u

RT @jd_wilko: Individualised gonadotropin dose selection using markers of ovaria... https://t.co/eGY4JvyqCG Our new review of personalised…

Individualised gonadotropin dose selection using markers of ovaria... https://t.co/eGY4JvyqCG Our new review of personalised IVF. Effect on birth rates vs ‘150IU for all’ could be 5 points either way.

New #Cochrane review evaluates the evidence for use of individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI): https://t.co/WpSUXJRopY

Individualised stimulation dose using ovarian reserve markers in women doing in vitro… https://t.co/eyqPzHAJZU